We used KTFR to stimulate NSCLC cells with overexpression of ADAMTS1 and found that inhibition of TGF-β activation by KTFR could reverse the effects of ADAMTS1 on the biological behavior and EMT of NSCLC cells. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.